However, the identification of germline TP53 or BAP1 mutations is important to be able to identify patients with Li-Fraumeni syndrome or BAP1 cancer syndrome and is the first step for proper genetic counseling and management of the patients and family members. The gene discussed is BAP1; the disease is Li-Fraumeni syndrome.